MeVis Medical Solutions AG
M3V
Rank in Stocks
#23644
MeVis Medical Solutions AG develops software for recording, analyzing, and... MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; as well as provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. In addition, the company provides three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians; and internet-based special applications in teleradiology. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.
Share Price
$22.11
Last synced: 2026-11-09
Market Cap
$40.24M
Change (1 day)
0.67%
Change (1 year)
-23.05%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MeVis Medical Solutions AG (M3V)
Category
Technology
EPS for MeVis Medical Solutions AG (M3V)
EPS as of March 2026 TTM: $0.85
According to MeVis Medical Solutions AG's latest financial reports, its current EPS (TTM) is $0.85. At the end of 2025 the company had an EPS of $2.04, a decrease compared to its 2024 EPS of $2.80.
EPS history for MeVis Medical Solutions AG from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.85 | -58.46% |
| 2025 | $2.04 | -26.99% |
| 2024 | $2.80 | -2.16% |
| 2023 | $2.86 | -31.89% |
| 2022 | $4.20 | 45.03% |
| 2021 | $2.89 | -21.15% |
| 2020 | $3.67 | -24.00% |
| 2019 | $4.83 | -0.70% |
| 2018 | $4.86 | 33.15% |
| 2017 | $3.65 | 29.39% |
| 2016 | $2.82 | -30.87% |
| 2015 | $4.08 | 56.22% |
| 2014 | $2.61 | -11.19% |
| 2013 | $2.94 | 77.06% |
| 2012 | $1.66 | -153.95% |
| 2011 | $-3.08 | -52.87% |
| 2010 | $-6.54 | -2,082.38% |
| 2009 | $0.33 | -80.44% |
| 2008 | $1.69 | 578.59% |
| 2007 | $0.25 | -96.53% |
| 2006 | $7.16 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $7.91 | 832.92% |
DE
|
|
| $1.66 | 95.87% |
CA
|
|
| $11.00 | 1,197.94% |
US
|
|
| $1.70 | 100.59% |
US
|
|
| $14.91 | 1,659.29% |
US
|
Questions about MeVis Medical Solutions AG's earnings per share (EPS)
What is MeVis Medical Solutions AG's earnings per share (EPS)?
MeVis Medical Solutions AG's earnings per share (EPS) over the last twelve months is $0.85, as of Mar 2026.
What was MeVis Medical Solutions AG's earnings per share (EPS) in 2025?
In 2025, MeVis Medical Solutions AG's earnings per share (EPS) was $2.04, 27.14% less than in 2024 ($2.80).
How has MeVis Medical Solutions AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, MeVis Medical Solutions AG's earnings per share (EPS) went from $3.67 to $2.04, an average decline of 11.08% a year.
How does MeVis Medical Solutions AG's earnings per share (EPS) compare with similar companies?
MeVis Medical Solutions AG's earnings per share (EPS) ($0.85) is lower than that of all 5 similar companies listed above. The highest among them is AppLovin Corporation, with $14.91.